NYSE American - Delayed Quote • USD
NanoViricides, Inc. (NNVC)
At close: 3:51 PM EDT
After hours: 5:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
| Low Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
| High Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
| Year Ago EPS | -0.14 | -0.15 | -- | -0.73 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 3/31/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.17 | -0.16 | -0.17 | -0.19 |
| EPS Actual | -0.14 | -0.15 | -0.15 | -0.18 |
| Difference | 0.03 | 0.01 | 0.02 | 0.01 |
| Surprise % | 17.60% | 6.30% | 11.80% | 5.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.19 | -0.2 | -0.73 | -1.11 |
| 7 Days Ago | -0.19 | -0.2 | -0.73 | -1.11 |
| 30 Days Ago | -0.19 | -0.2 | -0.73 | -1.11 |
| 60 Days Ago | -0.19 | -0.2 | -0.73 | -1.11 |
| 90 Days Ago | -0.17 | -0.17 | -0.68 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NNVC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -35.70% | -- | -- | 6.50% |
| Next Qtr. | -33.30% | -- | -- | 12.00% |
| Current Year | -- | -- | -- | 5.30% |
| Next Year | -52.10% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | EF Hutton: Buy to Buy | 2/16/2024 |
| Reiterates | EF Hutton: Buy | 4/18/2023 |
Related Tickers
NLSP NLS Pharmaceutics Ltd.
0.1367
+3.25%
IPIX Innovation Pharmaceuticals Inc.
0.0030
+50.00%
EDSA Edesa Biotech, Inc.
4.4199
-0.00%
CTNM Contineum Therapeutics, Inc.
15.72
-1.69%
TVGN Tevogen Bio Holdings Inc.
1.0000
+17.65%
INAB IN8bio, Inc.
1.0400
0.00%
IMNN Imunon, Inc.
1.4400
0.00%
ELYM Eliem Therapeutics, Inc.
3.9800
+17.40%
CNSP CNS Pharmaceuticals, Inc.
0.2150
+2.87%
CHRO Chromocell Therapeutics Corporation
1.6000
+6.67%